Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. (Q48694002)

14 February 2018

title

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. (English)

1 reference

14 February 2018

main subject

heart failure

0 references

congestive heart failure

1 reference

Koglin J

1

1 reference

14 February 2018

Pehlivanli S

2

1 reference

14 February 2018

Schwaiblmair M

3

1 reference

14 February 2018

Vogeser M

4

1 reference

14 February 2018

Cremer P

5

1 reference

14 February 2018

vonScheidt W

6

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 December 2001

1 reference

14 February 2018

Journal of the American College of Cardiology

published in

1 reference

14 February 2018

volume

38

1 reference

14 February 2018

issue

7

1 reference

14 February 2018

page(s)

1934-1941

1 reference

14 February 2018

Prognosis of congestive heart failure and predictors of mortality

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Predictors of prognosis in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Prediction of outcome in late-stage cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Biochemical detection of left-ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Natriuretic peptide system in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Lung function and cardiopulmonary exercise performance after heart transplantation: influence of cardiac allograft vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Hormones and hemodynamics in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

1 reference

7 January 2021

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901672-2

7 January 2021

10.1016/S0735-1097(01)01672-2

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

11738297

1 reference

14 February 2018